Homepage - Pancreatic Cancer Europe

Pancreatic Cancer Europe is a European multi-stakeholder platform which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.

News

PCE Early Career Investigator (ECI) Short-term Scientific Stay Award (S3A) – 2023

March 9, 2023

THE ORGANISATION The Pancreatic Cancer Europe (PCE) is a European multi-stakeholder platform, which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer. THE AWARD PCE launches a call for a short-term scientific ...Read More »

The European Health Technology Assessment Regulation: the political will, 28 Feb 15:00 – 16:30 (CET)

January 26, 2023

Cooperation among pharma companies, patients, and patient organisations can bring significant public health benefits. In building strong partnerships, it is important that all parties openly share their views about the relevance and benefit of their collaboration. Cooperation among all relevant stakeholders is particularly crucial at this point in time during the implementation period of the ...Read More »

Communication Officer Vacancy

January 6, 2023

PCE is recruiting a Communication Officer for the Communication activities of the association, including institutional and project-related communication. The Communication Officer will work part-time and at a distance, in close cooperation with PCE Secretariat. PCE will provide guidance and support, although the position is independent, and consequently, the Communication Officer can organise the work as ...Read More »

Junior Data Manager vacancy

November 25, 2022

PCE is recruiting a Junior Data Manager to implement and manage the PancreOs database on registries data, using the platform RedCap. PancreOS is a long-term project aiming at establishing a European platform of stakeholders working on the creation of a network of European Registries on pancreatic cancer. The platform will contain clinical and epidemiological information, ...Read More »

PancreOS Project Report

November 22, 2022

Pancreatic cancer is the only cancer with mortality on the rise in both sexes and is currently the 4th largest cause of death by cancer in Europe. Pancreatic cancer registries are a prerequisite if advances in pancreatic cancer research are to be made and the commitments of Member States to effective cancer control fulfilled. To ...Read More »

17 November 2022, “The importance of pancreatic cancer’s early detection” hosted by the European Parliament

October 31, 2022

On 17 November 2022, 15:30-17:00 (CET), PCE will promote the online event "The importance of pancreatic cancer’s early detection", hosted by the European Parliament. The initiative, organized in the framework of World Pancreatic Cancer Day (WPCD), will allow organizations, researchers, patients and Members of the European Parliament to discuss the importance of early detection of ...Read More »

Pancreatic Cancer Heatmap now online!

Following several months of development, we are happy to unveil the PCE heatmap. Conceived as a powerful tool to compare the pancreatic cancer patients’ situation in each European country, the heatmap provides information on awareness situation, national policy, diagnosis, research… We are always looking for more data and information to enrich the heatmap. Should you want to add some data for your country, please contact directly the Secretariat.

Visit the PCE heatmap ›

Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?

pancreatic cancer europe

Help us to reverse the Trend!

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 2020³.

Launched in July 2014 a call for action on pancreatic cancer by Members of the European Parliament has been the key driver for the activities of the platform. Since its launch, Pancreatic Cancer Europe has been developping the Pancreatic Cancer Declaration, in order to ensure real change in European policies for pancreatic cancer patients.

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Patients affected with pancreatic cancer lose 98% of their healthy life expectancy at the point of diagnosis⁵.

Today, a diagnosis of pancreatic cancer is generally associated with a death sentence and few patients are alive one year after diagnosis, while an earlier diagnosis could help reduce the mortality of the disease. If diagnosed in time, chances of survival increase.

Sources

Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543
Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
Pancreatic Cancer Action Network. The alarming rise of pancreatic cancer deaths in The United States: Why we need to stem the tide today, 2012. www.pancan.org/wp-content/uploads/2013/01/incidence_report_2012_executive_summary.pdf [Last accessed April 2014]
Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
Carrato A, Falcone A, Ducreux, M, Valle, J, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality-of-life, and costs. J Gastrointest Cancer 2015 Sep;46(3):201-11